Frontier IP success in Portugal recognised by the Department for International Trade

Frontier IP Chief Executive Officer Neil Crabb said: “We are honoured the DIT has recognised Frontier IP’s work in Portugal as we strive to reach our goal to be a leading IP commercialisation partner in the country. The DIT’s support has been invaluable and we look forward to building on our strong relationships with the Department and Portuguese universities.”

Frontier IP (LON:FIPP)The UK Department for International Trade has recognised Frontier IP’s success in Portugal by presenting the Group with the New to Market Award at the 10th anniversary of the DIT Business Awards in the country.

The award caps a year when the Group, which provides a range of commercialisation services to university spin outs in return for equity stakes, incorporated its first Portuguese portfolio company, a result of its formal relationship with the Universidade Nova de Lisboa Faculty of Science and Technology (“FCT Nova”).

NTPE is developing novel technology called Paper-E to print electronic circuits, sensors and semiconductors onto paper. More than 65 researchers are working on the project, and the Group holds a 31.6 per cent stake in the company.

Frontier IP also has a formal relationship with the Universidade de Évora and recently struck a partnership agreement with the British Embassy in Lisbon, which will provide strategic support to the Group.

HM Trade Commissioner for Europe Andrew Mitchell and Christopher Sainty, HM Ambassador to Portugal, presented the award to Frontier IP chief executive officer Neil Crabb at the Ambassador’s residence in Lisbon.

The DIT Business Awards, first launched in 2008, rewards and recognises UK companies who have achieved success in Portugal and the entrepreneurial effort of Portuguese companies which have chosen to invest in the UK.

Other UK companies to win awards included AstraZeneca, Barclays, Colt and Leonardo Helicopters.

HM Ambassador to Portugal Christopher Sainty said: “We are really quite proud to celebrate the business achievements of Frontier IP in Portugal and our modest contributions to their success. Congratulations.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Frontier IP Group Plc

    More articles like this

    Frontier IP Group Plc

    Animal Lovers and Zoonotic Diseases: 5 Things to Know

    Zoonotic diseases, or zoonoses, are on the rise. That may first bring to mind exotic diseases like Ebola, but the reality is that many zoonotic infections happen closer to home, often during everyday activities. In 2018,

    Frontier IP Group Plc

    AI-based initiatives catalyzing immunotherapy in 2018

    Artificial intelligence (AI) has been dynamically changing the field of drug discovery in several areas, including immunotherapy, oncotherapy, neurological disease, and many more. Described here is an ensemble of the initiatives in place to advance the field of

    Frontier IP Group Plc

    Frontier IP Group Plc appoint N+1 Singer as sole broker

    Frontier IP Group PLC (LON:FIPP), a specialist in commercialising university intellectual property, today announced the appointment of Nplus1 Singer Advisory LLP as the Group’s sole broker with immediate effect. Allenby Capital Limited remains the Group’s Nominated Adviser.

    Frontier IP Group Plc

    Britain’s university spinout sector is thriving

    They are among Britain’s greatest national treasures and a powerful engine of ideas and innovation for the nation’s booming technology industry. But how good are UK universities at commercialising the research and expertise which springs from

    Frontier IP Group Plc

    Exscientia CEO explains how AI is transforming drug discovery

    In recent decades a strange confluence has formed in the pharmaceutical industry. A range of powerful technologies have brought enormous new capabilities to the sector, productivity has been simultaneously declining. Deloitte’s Centre for Health Solutions estimates that projected returns on investment

    Frontier IP Group Plc

    How technology is revolutionising the healthcare industry

    A technology revolution is transforming the healthcare industry, changing everything from how patients are diagnosed and treated to our battle against some of the world’s most serious diseases. It’s a revolution fuelled by new sources of

    Frontier IP Group Plc

    Artificial Intelligence will Revolutionise Drug Discovery

    New technologies are making their way into the healthcare industry and healthcare providers are already experimenting with advances such as smart pill technology, 3D-printed medication, and mobile apps. But probably the biggest potential lies in artificial intelligence

    Frontier IP Group Plc

    Rallybio forges joint venture with U.K. tech firm

    A Farmington biotech startup formed by a trio of former top Alexion executives said it is working on drug discovery with an artificial intelligence company in the United Kingdom. Rallybio, focused on rare diseases, has not yet publicly

    Frontier IP Group Plc

    What is leptospirosis and how can it harm us and our pets?

    Recently reported cases of the often fatal bacterial infection leptospirosis in dogs in Sydney have raised the issue of animal diseases that also affect humans. This zoonotic disease is spread by rats and other rodents. However, this

    Frontier IP Group Plc

    The Robot Uprising Is Here

    The robot uprising is inevitable. Take the world’s first raspberry-picking robot, an autonomous machine that’s in development by Fieldwork Robotics at the University of Plymouth in the UK. This fruit-picking Terminator, so to speak, was developed for

    Frontier IP Group Plc

    The UK’s 50 Most Disruptive Companies Revealed

    After receiving applications from a wide range of early stage and more established companies from across industries, the initial list was whittled down to 100 by D/SRUPTION. The list was then submitted to an expert judging

    Frontier IP Group Plc

    Artificial intelligence in the world of drug discovery

    Charlotte Walker-Osborn, a Partner and Head of Technology Sector (International) at global law-firm Eversheds Sutherland and a legal expert in technology law, explains some of the challenges and potential future of artificial intelligence (AI) in the

    Frontier IP Group Plc

    11 diseases which can cause infection

    Illnesses that can pass from animals to humans are known as zoonotic. They’re surprisingly common: More than six out of every 10 known infectious diseases in people are actually contracted from animals, according to the CDC.